Time in therapeutic range among warfarin users in Turkey: Are there enough data to set definitive criteria for reimbursement?
Saved in:
Main Authors: | Mehmet Akif Topcuoglu (Author), Ethem Murat Arsava (Author) |
---|---|
Format: | Book |
Published: |
KARE Publishing,
2021-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Time in therapeutic range values of patients using warfarin and factors that influence time in therapeutic range
by: Lale Dinç Asarcıklı, et al.
Published: (2021) -
Long-term follow-up outcomes in a real-world study cohort after percutaneous patent foramen ovale closure
by: Ahmet Hakan Ateş, et al.
Published: (2021) -
Pharmaceutical Care Increases Time in Therapeutic Range of Patients With Poor Quality of Anticoagulation With Warfarin
by: Leiliane Rodrigues Marcatto, et al.
Published: (2018) -
Geographic Market Definition: The Case of Medicare-Reimbursed Skilled Nursing Facility Care
by: John R. Bowblis, et al.
Published: (2011) -
Decision-making criteria for medicine reimbursement in Slovenia: an expert panel discussion
by: Andreja Detiček, et al.
Published: (2018)